XML 61 R42.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Investments in Equity Securities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract] |
Investment | The carrying amount of our investments consisted of the following at December 31:
(in millions) |  | 2024 |  | 2023
ABI |  | $ | 7,880 |  |  | $ | 9,676 |
Cronos |  | 315 |  |  | 335 |
Total |  | $ | 8,195 |  |  | $ | 10,011 |
(Income) losses from our current and former investments in equity securities consisted of the following:
| For the Years Ended December 31, |
(in millions) | 2024 |  | 2023 |  | 2022 |
ABI (1) | $ | (673) |  | (2) | $ | (539) |  |  | $ | 1,973 |  |
Cronos (1) | 21 |  |  | 46 |  |  | 228 |  |
(Income) losses from investments under equity method of accounting | (652) |  |  | (493) |  |  | 2,201 |  |
JUUL | — |  |  | 250 |  | (3) | 1,455 |  | (4)
(Income) losses from investments in equity securities | $ | (652) |  |  | $ | (243) |  |  | $ | 3,656 |  |
(1) Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investments required under the equity method of accounting. (2) Includes $165 million of the total pre-tax gain on the ABI Transaction discussed below. (3) Represents the loss as a result of the disposition of our JUUL equity securities discussed below. (4) Represents the estimated change in fair value. Prior to the disposition of our JUUL equity securities in March 2023, we accounted for our former investment in JUUL as an investment in an equity security measured at fair value. Investees’ summarized financial data for our equity method investments was as follows:
| For Altria’s Year Ended December 31,
| 2024 (1) |  | 2023 (1) |  | 2022 (1)
(in millions) | ABI |  | Other Investments |  | ABI |  | Other Investments |  | ABI |  | Other Investments
Net revenues | $ | 60,103 |  |  | $ | 111 |  |  | $ | 59,841 |  |  | $ | 87 |  |  | $ | 57,267 |  |  | $ | 947 |
Gross profit | $ | 32,974 |  |  | $ | 17 |  |  | $ | 32,371 |  |  | $ | 9 |  |  | $ | 31,588 |  |  | $ | 525 |
Earnings (losses) from continuing operations | $ | 8,108 |  |  | $ | (48) |  |  | $ | 7,956 |  |  | $ | (105) |  |  | $ | 7,879 |  |  | $ | (521) |
Net earnings (losses) | $ | 8,108 |  |  | $ | (49) |  |  | $ | 7,956 |  |  | $ | (108) |  |  | $ | 7,879 |  |  | $ | (521) |
Net earnings (losses) attributable to equity investments | $ | 6,501 |  |  | $ | (47) |  |  | $ | 6,284 |  |  | $ | (108) |  |  | $ | 5,838 |  |  | $ | (520) |
(1) Reflects a one-quarter lag. Other Investments reflect summarized financial data of Cronos, as well as JUUL’s financial data for the periods during which we accounted for our former investment in JUUL as an equity method investment under the fair value option.
| At September 30,
| 2024 (2) |  | 2023 (2)
(in millions) | ABI |  | Other Investments |  | ABI |  | Other Investments
Current assets | $ | 22,525 |  |  | $ | 959 |  |  | $ | 22,835 |  |  | $ | 918 |
Long-term assets | $ | 185,318 |  |  | $ | 225 |  |  | $ | 188,003 |  |  | $ | 232 |
Current liabilities | $ | 31,182 |  |  | $ | 40 |  |  | $ | 35,407 |  |  | $ | 31 |
Long-term liabilities | $ | 92,377 |  |  | $ | 13 |  |  | $ | 91,791 |  |  | $ | 3 |
Noncontrolling interests | $ | 10,831 |  |  | $ | 50 |  |  | $ | 11,231 |  |  | $ | (3) |
(2) Reflects a one-quarter lag. Other Investments reflect summarized financial data of Cronos.
Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure | As a result of the ABI Transaction, we recorded the following pre-tax amounts in our consolidated statement of earnings:
(in millions) | For the Year Ended December 31, 2024 |  |
Gain on partial sale of our investment | $ | 165 |  |  |  |  |  |  |
Transaction costs | (62) |  |  |  |  |  |  |
Total pre-tax gain on ABI Transaction | $ | 103 |  |  |  |  |  |  |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The following table provides a reconciliation of the beginning and ending balance of our former investment in JUUL, which was classified in Level 3 of the fair value hierarchy prior to the disposition of our JUUL equity securities:
(in millions) |  | Investment Balance
Balance at December 31, 2022 |  | $ | 250 |
Non-cash, pre-tax (loss) on disposition included in (income) losses from investments in equity securities |  | (250) |
Balance at December 31, 2023 |  | $ | — |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 101 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-101 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 321 -Publisher FASB -URI https://asc.fasb.org/321/tableOfContent Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 325 -Publisher FASB -URI https://asc.fasb.org/325/tableOfContent + Details
Name: | us-gaap_InvestmentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration